BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7691025)

  • 1. Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease.
    Haneda N; Mori C
    Acta Paediatr Jpn; 1993 Aug; 35(4):294-7. PubMed ID: 7691025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose gammaglobulin therapy for Kawasaki disease.
    Nagashima M; Matsushima M; Matsuoka H; Ogawa A; Okumura N
    J Pediatr; 1987 May; 110(5):710-2. PubMed ID: 2437278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant right coronary artery aneurysm secondary to Kawasaki disease in child: a case report.
    Zhang S; Liu G; Yu T; Zhou G; Zheng R
    Int J Clin Exp Pathol; 2015; 8(8):9468-70. PubMed ID: 26464706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease.
    Liu AM; Ghazizadeh M; Onouchi Z; Asano G
    Microvasc Res; 1999 Jul; 58(1):10-27. PubMed ID: 10388599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms.
    Yonesaka S; Takahashi T; Eto S; Sato T; Otani K; Ueda T; Sato A; Kitagawa Y; Konno Y; Kinjo M
    Cardiol Young; 2010 Dec; 20(6):602-9. PubMed ID: 20584347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings.
    Suzuki A; Miyagawa-Tomita S; Nakazawa M; Yutani C
    Jpn Heart J; 2000 May; 41(3):245-56. PubMed ID: 10987345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
    Wu JR; Hwang KP; Tu JG; Dai ZK; Huang TY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan; 9(1):27-38. PubMed ID: 7682261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens.
    Onouchi Z; Hamaoka K; Sakata K; Ozawa S; Shiraishi I; Itoi T; Kiyosawa N
    Circ J; 2005 Mar; 69(3):265-72. PubMed ID: 15731529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous gammaglobulin for Kawasaki disease.
    Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
    Lancet; 1984 Nov; 2(8411):1055-8. PubMed ID: 6209513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease.
    Daniels SR; Specker B; Capannari TE; Schwartz DC; Burke MJ; Kaplan S
    Am J Dis Child; 1987 Feb; 141(2):205-7. PubMed ID: 3812389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intravenous gamma-globulin therapy in Kawasaki disease.
    Hwang BT; Lin CY; Hsieh KS; Tsuei DH; Meng CC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(1):15-22. PubMed ID: 2484055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New hope for children with Kawasaki disease.
    Lux KM
    J Pediatr Nurs; 1991 Jun; 6(3):159-65. PubMed ID: 1710660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kawasaki disease: new and important problems in cardiology].
    Kato H; Ichinose E
    J Cardiogr; 1983 Sep; 13(3):731-47. PubMed ID: 6678300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of coronary abnormalities in patients after Kawasaki disease.
    Fukushige J; Takahashi N; Ueda K; Hijii T; Igarashi H; Ohshima A
    Pediatr Cardiol; 1996; 17(2):71-6. PubMed ID: 8833489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
    Sato N; Sugimura T; Akagi T; Yamakawa R; Hashino K; Eto G; Iemura M; Ishii M; Kato H
    Pediatr Int; 1999 Feb; 41(1):1-7. PubMed ID: 10200128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives in the drug treatment of Kawasaki disease.
    Shingadia D; Shulman ST
    Paediatr Drugs; 1999; 1(4):291-7. PubMed ID: 10935427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
    Tavli V; Yilmazer MM; Güven B; Meşe T; Oner T; Demirpençe S
    Turk Kardiyol Dern Ars; 2010 Jan; 38(1):20-4. PubMed ID: 20215838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki Disease.
    Nishihara S; Ishibashi K; Iribe K; Matsuda I
    Lancet; 1988 Oct; 2(8617):973. PubMed ID: 2459575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.